The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...

The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...

The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...

UnitedHealth (UNH) and Cigna (CI) are under pressure as the FTC looks to resume a lawsuit against their PBMs. Read more here.

Created in 1914, the FTC is tasked with stopping unfair trade practices — particularly those by big corporations that use ...

The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...

A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

The agency has paused its lawsuit against three pharmacy-benefit managers because no current commissioners can participate in ...

A Federal Trade Commission case against insulin price gouging has come to a screeching halt after two Democratic commissioners were fired by President Donald Trump.

The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes patients towards higher priced insulin in order to reap millions of ...